- Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling.
- They hope that training thousands of employees on generative AI will boost productivity in drug development.
- This article is part of “AI in Action,” a series exploring how companies are implementing AI innovations.
Johnson & Johnson is embracing the concept of a bilingual employee — but not in the classic sense.
For the pharmaceutical company,…
Article Source
https://www.businessinsider.com/pharmaceutical-companies-embrace-ai-in-drug-discovery-efforts-2025-3